Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRPT | BMY | AMGN | GILD | MRNA |
| Company | Sarepta Therapeutics | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 117.55 | 47.93 | 265.64 | 67.01 | 102.53 |
| High | 118.90 | 48.41 | 265.92 | 67.02 | 103.50 |
| Low | 115.79 | 47.62 | 262.58 | 65.90 | 99.90 |
| Last | 116.55 | 48.30 | 262.75 | 66.16 | 102.00 |
| Change | -1.34 | +0.46 | -1.32 | -0.77 | -1.44 |
| % Change | -1.14% | +0.96% | -0.50% | -1.15% | -1.39% |
| Volume | 498,500 | 10,917,500 | 2,082,700 | 6,442,200 | 1,798,400 |
| 20-Day Average Volume | 591,810 | 11,419,555 | 2,201,900 | 6,214,910 | 3,243,145 |
| Previous Close | 117.89 | 47.84 | 264.07 | 66.93 | 103.44 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 124.98 | 50.99 | 272.96 | 70.21 | 105.46 |
| 20-Day Raw Stochastic | 4.94% | 9.99% | 0.65% | 3.10% | 26.47% |
| 20-Day Relative Strength | 37.84% | 37.48% | 36.64% | 27.91% | 48.81% |
| Weighted Alpha | +2.81 | -30.16 | +4.25 | -25.27 | -19.77 |
| Today's Opinion | 40% Buy | 72% Sell | 56% Sell | 100% Sell | 72% Buy |
| Previous Opinion | 40% Buy | 56% Sell | 56% Sell | 100% Sell | 72% Buy |
| Last Month's Opinion | 56% Buy | 24% Sell | 8% Sell | 88% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.35% since 04/11/24 | -1.67% since 04/11/24 | -2.69% since 04/11/24 | -3.63% since 04/11/24 | -4.68% since 04/11/24 |
| Low | 115.79 on 04/18/24 | 47.62 on 04/18/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 99.90 on 04/18/24 |
| High | 124.82 on 04/12/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 107.88 on 04/12/24 |
| 1-Month | |||||
| %Chg | -5.99% since 03/18/24 | -6.38% since 03/18/24 | -3.01% since 03/18/24 | -9.69% since 03/18/24 | -2.17% since 03/18/24 |
| Low | 115.79 on 04/18/24 | 47.62 on 04/18/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 97.00 on 04/03/24 |
| High | 131.16 on 03/28/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | -0.21% since 01/18/24 | -3.57% since 01/18/24 | -13.71% since 01/18/24 | -23.43% since 01/18/24 | +2.96% since 01/18/24 |
| Low | 114.48 on 01/19/24 | 47.58 on 02/06/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 84.06 on 02/13/24 |
| High | 143.00 on 02/16/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | +2.40% since 10/18/23 | -15.04% since 10/18/23 | -7.35% since 10/18/23 | -16.96% since 10/18/23 | +18.59% since 10/18/23 |
| Low | 55.25 on 10/31/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 62.55 on 11/02/23 |
| High | 143.00 on 02/16/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,069,871 | 96,960,152 | 141,520,144 | 83,333,008 | 39,605,108 |
| Shares Outstanding, K | 93,900 | 2,026,759 | 535,919 | 1,245,077 | 382,880 |
| Annual Sales | 1,243,340,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -535,980,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 396,780,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,811,000,000 |
| Last Quarter Net Income | 45,650,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 217,000,000 |
| 60-Month Beta | 0.94 | 0.39 | 0.58 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.47 on 02/28/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 05/07/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.43 | 14.24 | 10.02 | 0.00 |